Energy Restriction as an Antitumor Target of Thiazolidinediones
Open Access
- 1 March 2010
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 285 (13), 9780-9791
- https://doi.org/10.1074/jbc.m109.065466
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- PPARγ-independent antitumor effects of thiazolidinedionesCancer Letters, 2009
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009
- Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes AmyloidogenesisNeuron, 2008
- Therapeutic starvation and autophagy in prostate cancer: A new paradigm for targeting metabolism in cancer therapyThe Prostate, 2008
- A Novel Mechanism by Which Thiazolidinediones Facilitate the Proteasomal Degradation of Cyclin D1 in Cancer CellsOnline Journal of Public Health Informatics, 2008
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005
- Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonistsThe Lancet Oncology, 2004
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000
- The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-cateninOncogene, 1999